Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
KPRXCompany Name
KIORA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKIORA PHARMACEUTICALS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPRX - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 8.1M | 0 | $ 0 |
| 3/31/2025 | $ 9.89M | 494.63 | $ 20K |
| 12/31/2024 | $ 9.12M | 0.57 | $ 16.02M |
| 9/30/2024 | $ 10.58M | 0.66 | $ 16.02M |
| 6/30/2024 | $ 9.95M | 0.62 | $ 16.02M |
| 3/31/2024 | $ 12.77M | 0.8 | $ 16M |
| 12/31/2023 | $ 15.26M | 0 | $ 0 |
| 9/30/2023 | $ 4.99M | 0 | $ 0 |
| 6/30/2023 | $ 4.06M | 0 | $ 0 |
| 3/31/2023 | $ 5.12M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- KIORA PHARMACEUTICALS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, KIORA PHARMACEUTICALS INC's average P/S has been 1.03K.
- The median P/S for KIORA PHARMACEUTICALS INC during this period was 494.63
- KIORA PHARMACEUTICALS INC reached its highest P/S over the past 5 years at 2.98K.
- The lowest P/S recorded by KIORA PHARMACEUTICALS INC in the same timeframe 0.57
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for KIORA PHARMACEUTICALS INC is calculated as follows: Market Cap [ $ 15.27M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] KPRX - Price to Sales, Last 5 years
0.57
Minimum
Dec 31, 2024
2.98K
Maximum
Dec 31, 2020
1.03K
Average
494.63
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |